American Academy of Neurology (AAN) Guideline Summary for Patients and Their Families: Treatment for Guillain-Barre Syndrome

QualityTool

American Academy of Neurology (AAN) Guideline Summary for Patients and Their Families: Treatment for Guillain-Barre Syndrome

Description

This patient tool describes different therapies for Guillain-Barré syndrome and the evidence for and against these treatments.

This tool addresses the following questions:

  • What is Guillain-Barré syndrome (GBS)?
  • What does “immunotherapy” mean?
  • What are the immunotherapy treatments used to treat GBS?
    • Intravenous immune globulin (IVIg)
    • Plasma exchange
    • Combined treatments
    • Steroids

Developer:

American Academy of Neurology

Funding Sources:

American Academy of Neurology

History

Release Date: 2003
Original Summary: October 2004
Last Updated: 07/31/13

QualityTool Classification

Disclaimer: The inclusion of a tool in the Innovations Exchange does not constitute or imply an endorsement by the U.S. Department of Health and Human Services, the Agency for Healthcare Research and Quality or Westat of the tool or of the submitter or developer of the tool. Read more.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information: verify here.